- Home
- SDOT vs INTS Comparison
SDOT vs INTS Comparison
Compare SDOT & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- INTS
- Stock Information
- Founded
- SDOT 2014
- INTS 2012
- Country
- SDOT United States
- INTS United States
- Employees
- SDOT N/A
- INTS N/A
- Industry
- SDOT Restaurants
- INTS Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- INTS Health Care
- Exchange
- SDOT Nasdaq
- INTS Nasdaq
- Market Cap
- SDOT 8.0M
- INTS 9.4M
- IPO Year
- SDOT 2020
- INTS 2023
- Fundamental
- Price
- SDOT $1.39
- INTS $0.30
- Analyst Decision
- SDOT
- INTS Strong Buy
- Analyst Count
- SDOT 0
- INTS 3
- Target Price
- SDOT N/A
- INTS $8.50
- AVG Volume (30 Days)
- SDOT 591.6K
- INTS 2.5M
- Earning Date
- SDOT 08-12-2025
- INTS 08-07-2025
- Dividend Yield
- SDOT N/A
- INTS N/A
- EPS Growth
- SDOT N/A
- INTS N/A
- EPS
- SDOT 1.07
- INTS N/A
- Revenue
- SDOT $726,598,000.00
- INTS N/A
- Revenue This Year
- SDOT $12.76
- INTS N/A
- Revenue Next Year
- SDOT $5.54
- INTS N/A
- P/E Ratio
- SDOT $1.30
- INTS N/A
- Revenue Growth
- SDOT 18.91
- INTS N/A
- 52 Week Low
- SDOT $1.12
- INTS $0.26
- 52 Week High
- SDOT $7.00
- INTS $5.10
- Technical
- Relative Strength Index (RSI)
- SDOT 47.94
- INTS 36.77
- Support Level
- SDOT $1.33
- INTS $0.29
- Resistance Level
- SDOT $1.52
- INTS $0.35
- Average True Range (ATR)
- SDOT 0.20
- INTS 0.04
- MACD
- SDOT -0.01
- INTS 0.02
- Stochastic Oscillator
- SDOT 12.99
- INTS 35.10
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.